SOPAX
Price
$32.10
Change
+$0.28 (+0.88%)
Updated
Dec 3 closing price
Net Assets
8.94B
VVIAX
Price
$74.33
Change
+$0.66 (+0.90%)
Updated
Dec 3 closing price
Net Assets
207.95B
Interact to see
Advertisement

SOPAX vs VVIAX

Header iconSOPAX vs VVIAX Comparison
Open Charts SOPAX vs VVIAXBanner chart's image
ClearBridge Dividend Strategy A
Price$32.10
Change+$0.28 (+0.88%)
VolumeN/A
Net Assets8.94B
Vanguard Value Index Adm
Price$74.33
Change+$0.66 (+0.90%)
VolumeN/A
Net Assets207.95B
SOPAX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
SOPAX vs. VVIAX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SOPAX is a Buy and VVIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 208B vs. SOPAX (8.94B). VVIAX pays higher dividends than SOPAX: VVIAX (2.04) vs SOPAX (1.09). SOPAX was incepted earlier than VVIAX: SOPAX (33 years) vs VVIAX (25 years). SOPAX (1.00) is less costly to investors than VVIAX (0.05). SOPAX is a more actively managed with annual turnover of: 19.00 vs. VVIAX (9.00). SOPAX has a lower initial minimum investment than VVIAX: SOPAX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 6.10 vs. SOPAX (-1.70). VVIAX return over 5 years is better than : 60.40 vs. SOPAX (27.89).
SOPAXVVIAXSOPAX / VVIAX
Total Expense Ratio1.000.052,000%
Annual Report Gross Expense Ratio1.000.052,000%
Fund Existence33 years25 years-
Gain YTD9.30312.64074%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets8.94B208B4%
Annual Yield % from dividends1.092.0453%
Returns for 1 year-1.706.10-28%
Returns for 3 years16.2230.8253%
Returns for 5 years27.8960.4046%
Returns for 10 years81.00128.9063%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALLO1.520.18
+13.43%
Allogene Therapeutics
BCAB0.830.05
+6.00%
BioAtla
AGIO27.490.51
+1.89%
Agios Pharmaceuticals
WTGUU10.30N/A
N/A
Wintergreen Acquisition Corp.
UGI37.64-0.49
-1.29%
UGI Corp